Ceftolozane-Tazobactam Pharmacokinetics during Extracorporeal Membrane Oxygenation in a Lung Transplant Recipient

Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02131-18. doi: 10.1128/AAC.02131-18. Print 2019 Mar.
No abstract available

Keywords: Pseudomonas aeruginosa; multidrug resistance; pharmacokinetics; therapeutic drug monitoring; transplantation.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use*
  • Cephalosporins / blood
  • Cephalosporins / therapeutic use*
  • Extracorporeal Membrane Oxygenation / methods*
  • Female
  • Humans
  • Lung Transplantation
  • Microbial Sensitivity Tests
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas aeruginosa / drug effects
  • Tazobactam / blood
  • Tazobactam / therapeutic use*
  • Transplant Recipients
  • beta-Lactamase Inhibitors / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • beta-Lactamase Inhibitors
  • ceftolozane, tazobactam drug combination
  • Tazobactam